CHICAGO, April 30, 2024 /PRNewswire/ -- Dental
Bone Graft Substitutes Market in terms of revenue was
estimated to be worth $1.3 billion in
2024 and is poised to reach $1.8
billion by 2029, growing at a CAGR of 7.7% from 2024 to 2029
according to a new report by MarketsandMarkets™.
The global population is growing older, leading to an increased
demand for dental bone graft substitute also the increasing
popularity of dental implants as a tooth replacement option creates
a direct need for bone graft substitutes which is expected to drive
the market growth. However, high material costs and surgical costs
associated with hospital or clinic fees, surgeon fees, and
anesthesia is expected to challenge the growth of the market.
This report divides dental bone graft substitute into four
segments – type, application, mechanism, product, end user and
region.
Download an Illustrative overview:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=159678690
Browse in-depth TOC on "Dental Bone Graft Substitutes
Market"
260 - Tables
50 - Figures
400
- Pages
Dental Bone Graft Substitutes Market Scope:
Report
Coverage
|
Details
|
Market Revenue in
2024
|
$1.3 billion
|
Estimated Value by
2029
|
$1.8 billion
|
Growth Rate
|
Poised to grow at a
CAGR of 7.7%
|
Market Size Available
for
|
2022–2029
|
Forecast
Period
|
2024–2029
|
Forecast
Units
|
Value (USD
Billion)
|
Report
Coverage
|
Revenue Forecast,
Competitive Landscape, Growth Factors, and Trends
|
Segments
Covered
|
Dental bone graft
substitute – Type, Application, Mechanism, Product, End User and
Region.
|
Geographies
Covered
|
Asia Pacific, North
America, Europe, Latin America, and the Middle East and Africa and
GCC countries
|
Report
Highlights
|
Updated financial
information / product portfolio of players
|
Key Market
Opportunities
|
Growing Prevalence of
Dental Disorders
|
Key Market
Drivers
|
Rising aging
population
|
"Based on dental bone graft substitute by end user, the
hospitals segment is expected to grow at the highest CAGR
during the forecast period."
Under end user, hospital segment is forecasted to grow at the
highest CAGR from 2024 to 2029., Bone grafting is frequently used
in hospitals for oral and maxillofacial surgery for procedures like
jaw reconstruction, alveolar ridge preservation, cleft lip and
palate repair and dental implantology, when natural jawbone is
insufficient for implant placement, bone grafts provide a
foundation for successful implant osseointegration (fusion with
bone).
"The Bio-Oss segment is expected to account for the
largest share, by product in dental bone graft substitute."
By product segment, dental bone graft substitute is segmented
into Bio-Oss, osteograf, grafton and others. Bio-Oss accounts for
the largest share in by product category. Bio-Oss has a long
history of successful use in dental bone grafting procedures, with
extensive clinical research supporting its efficacy and safety
which is expected to drive the segment growth.
"The osteoconduction segment is expected to account for the
largest share, by mechanism in dental bone graft
substitute."
By mechanism segment, dental bone graft substitute is segmented
into bio osteoconduction, osteoinduction, osteopromotion,
osteogenesis. osteoconduction accounts for the largest share in by
mechanism category. Osteoconduction promotes bone regeneration at
the defect site, provides a foundation for dental implant placement
and supports jawbone structure and prevents collapse which is
expected to drive the segment growth.
"In 2023, Europe was the
region with the second largest market share in dental bone graft
substitute. "
Dental bone graft substitute is segmented into five major
regions, namely, North America,
Europe, Asia Pacific (APAC), Latin America, and the Middle East and Africa and GCC countries.
Europe accounted for the
second-largest share of dental bone graft substitute in 2023. The
apidly aging population, leading to a higher demand for dental bone
graft substitute is driving the growth of dental bone graft
substitute in the European region.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=159678690
Dental Bone Graft Substitutes Market Dynamics:
Drivers:
- Rising aging population
Restraints:
- Stringent regulatory guidelines for medical devices
Opportunities:
- Growing Prevalence of Dental Disorders
Challenge:
- High Surgical Procedures Costs
Key Market Players of Dental Bone Graft Substitutes
Industry:
Key players in dental bone graft substitute include Dentsply
Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON &
JOHNSON (US), Stryker Corporation
(US), Medtronic, Plc (Ireland),
Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry
Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health
(US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings
Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd.
(Japan), BEGO GmbH & Co. KG
(Germany), Young Innovations (US),
Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC
(US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox
International Corp.(Taiwan), Meyer
Haake GMBH (Germany) and
Arora Biosurgery Ltd. (New
Zealand).
A breakdown of the primary participants (supply-side) for the
dental bone graft substitute market referred to for this report is
provided below:
- By Company Type: Tier 40%, Tier 35%, and Tier 25%
- By Designation: C-level–30%, Director Level–55%, and
Others–15%
- By Region: North America–20%, Europe–15%, Asia Pacific–25%,
Latin America- 10%, Middle East & Africa-30%.
Get 10% Free Customization on this Report:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=159678690
Recent Developments of Dental Bone Graft Substitutes
Industry:
- In April 2023, Henry Schein acquired a majority ownership
position in Biotech Dental, aiming to create a digital workflow
that provides a seamless journey for customers to increase case
acceptance and improve clinical outcomes for practitioners.
- In March 2022, Dentsply Sirona
Inc. partnered with Platform for Better Oral Health in Europe. The goal is to improve oral health and
the prevention of oral diseases - as well as address oral health
inequalities and challenges.
- In February 2022, Envista
Holdings Corporation (US) partnered with Vitaldent Group
(Spain). This extended agreement
positions Envista as the preferred supplier of implants (Nobel
Biocare) and clear aligners (Spark).
- In January 2022, Johnson &
Johnson partnered with Microsoft Corporation, Inc. The Johnson
& Johnson Medical Devices Companies (JJMDC) collaborated with
Microsoft Corporation Inc, (US) to enable and expand JJMDC's secure
and compliant digital surgery ecosystem.
Dental Bone Graft Substitutes Market - Key Benefits of Buying
the Report:
The report will help the market leaders/new entrants in this
market with information on the closest approximations of the
revenue numbers for the overall dental bone graft substitute market
and the subsegments. This report will help stakeholders understand
the competitive landscape and gain more insights to position their
businesses better and plan suitable go-to-market strategies. The
report also helps stakeholders understand the pulse of the market
and provides them with information on key market drivers,
restraints, challenges, and opportunities.
This report provides insights into the following
pointers:
- Analysis of key drivers (growing market for dental tourism in
emerging countries, increasing disposable income in developing
counties, rising cases of dental caries and the subsequent increase
in tooth repair procedures, changing demographics), restraints
(lack of proper reimbursement scenario, stringent regulations
pertaining to medical devices used in dentistry, dearth of trained
dental practitioners), opportunities (increasing demand from
customers and rising inclination towards cosmetic dentistry, low
penetration rates for dental bone graft substitutes, consolidation
of dental practices and rising do activity, growing demand for bone
graft substitutes from emerging markets) and challenges (pricing
pressure faced by prominent market players)
- Market Penetration: It includes extensive information on
product portfolios offered by the major players in the global
dental bone graft substitute market. The report includes various
segments in market type, application, mechanism, product, end user
and region.
- Product Enhancement/Innovation: Comprehensive details about new
product launches and anticipated trends in the global dental bone
graft substitute market.
- Market Development: Thorough knowledge and analysis of the
profitable rising markets type, application, mechanism, product,
end user and region
- Market Diversification: Comprehensive information about newly
launched product and services, expanding markets, current
advancements, and investments in the global dental bone graft
substitute market.
- Competitive Assessment: Thorough evaluation of the market
shares, growth plans, offerings of product and services, and
capacities of the major competitors in the global dental bone graft
substitute market.
Related Reports:
Dental Implants and Prosthetics Market - Global Forecasts
to 2029
Biomaterials Market - Global Forecasts to 2029
Restorative Dentistry Market - Global Forecasts to
2028
Medical Ceramics Market - Global Forecasts to 2027
Dental Consumables Market - Global Forecasts to 2027
Get access to the latest updates on Dental Bone Graft
Substitutes Companies and Dental Bone Graft Substitutes Market
Share
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's
best management consulting firms by Forbes, as per their recent
report.
MarketsandMarkets™ is a blue ocean alternative in growth
consulting and program management, leveraging a man-machine
offering to drive supernormal growth for progressive organizations
in the B2B space. We have the widest lens on emerging technologies,
making us proficient in co-creating supernormal growth for
clients.
Earlier this year, we made a formal transformation into one of
America's best management consulting firms as per a survey
conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are
substituting existing revenue streams in this decade alone. We work
with clients on growth programs, helping them monetize this
$25 trillion opportunity through our
service lines - TAM Expansion, Go-to-Market (GTM) Strategy to
Execution, Market Share Gain, Account Enablement, and Thought
Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several
Forbes Global 2000 B2B companies - helping them stay relevant in a
disruptive ecosystem. Our insights and strategies are molded by our
industry experts, cutting-edge AI-powered Market Intelligence
Cloud, and years of research. The KnowledgeStore™ (our Market
Intelligence Cloud) integrates our research, facilitates an
analysis of interconnections through a set of applications, helping
clients look at the entire ecosystem and understand the revenue
shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us
on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Logo:
https://mma.prnewswire.com/media/1951202/4609423/MarketsandMarkets.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/dental-bone-graft-substitutes-market-worth-1-8-billion--marketsandmarkets-302131596.html